Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis

Data regarding the efficacy and tolerability of elbasvir/grazoprevir (EBR/GZR) for East-Asian hepatitis C virus genotype 1b (HCV GT1b) patients receiving hemodialysis were limited. We prospectively recruited 40 HCV GT1b hemodialysis patients who received EBR/GZR for 12 weeks at 6 academic centers in...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chen-Hua, Peng, Cheng-Yuan, Fang, Yu-Jen, Kao, Wei-Yu, Yang, Sheng-Shun, Lin, Cheng-Kuan, Lai, Hsueh-Chou, Su, Wen-Pang, Fang, Sheng-Uei, Chang, Chun-Chao, Su, Tung-Hung, Liu, Chun-Jen, Chen, Pei-Jer, Chen, Ding-Shinn, Kao, Jia-Horng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280513/
https://www.ncbi.nlm.nih.gov/pubmed/32513953
http://dx.doi.org/10.1038/s41598-020-66182-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280513/
https://www.ncbi.nlm.nih.gov/pubmed/32513953
http://dx.doi.org/10.1038/s41598-020-66182-8

Ejemplares similares